nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2C19—urine—hypothyroidism	0.0228	0.0754	CbGeAlD
Etoricoxib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.02	0.0319	CcSEcCtD
Etoricoxib—CYP1A2—urine—hypothyroidism	0.0186	0.0616	CbGeAlD
Etoricoxib—CYP2C9—urine—hypothyroidism	0.0176	0.0585	CbGeAlD
Etoricoxib—Epigastric discomfort—Liotrix—hypothyroidism	0.0172	0.0274	CcSEcCtD
Etoricoxib—CYP2E1—urine—hypothyroidism	0.0167	0.0554	CbGeAlD
Etoricoxib—Angina pectoris—Liothyronine—hypothyroidism	0.0153	0.0244	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0138	0.022	CcSEcCtD
Etoricoxib—MAPK14—heart—hypothyroidism	0.0137	0.0454	CbGeAlD
Etoricoxib—Myocardial infarction—Liothyronine—hypothyroidism	0.0137	0.0219	CcSEcCtD
Etoricoxib—CYP3A4—urine—hypothyroidism	0.0135	0.0446	CbGeAlD
Etoricoxib—CYP2D6—urine—hypothyroidism	0.0132	0.0439	CbGeAlD
Etoricoxib—MAPK14—cardiovascular system—hypothyroidism	0.0129	0.0429	CbGeAlD
Etoricoxib—MAPK14—pituitary gland—hypothyroidism	0.0115	0.038	CbGeAlD
Etoricoxib—Arrhythmia—Liothyronine—hypothyroidism	0.0112	0.0179	CcSEcCtD
Etoricoxib—MAPK14—adrenal gland—hypothyroidism	0.0102	0.0339	CbGeAlD
Etoricoxib—MAPK14—blood—hypothyroidism	0.0102	0.0339	CbGeAlD
Etoricoxib—Cellulitis—Liotrix—hypothyroidism	0.00992	0.0158	CcSEcCtD
Etoricoxib—MAPK14—thyroid gland—hypothyroidism	0.00988	0.0327	CbGeAlD
Etoricoxib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00982	0.0157	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00982	0.0157	CcSEcCtD
Etoricoxib—MAPK14—female gonad—hypothyroidism	0.00955	0.0316	CbGeAlD
Etoricoxib—Hypertension—Liothyronine—hypothyroidism	0.00943	0.015	CcSEcCtD
Etoricoxib—Blood urea increased—Liotrix—hypothyroidism	0.00852	0.0136	CcSEcCtD
Etoricoxib—MAPK14—testis—hypothyroidism	0.00847	0.0281	CbGeAlD
Etoricoxib—Cardiac arrest—Levothyroxine—hypothyroidism	0.00847	0.0135	CcSEcCtD
Etoricoxib—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00847	0.0135	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.00832	0.117	CbGpPWpGaD
Etoricoxib—MAPK14—liver—hypothyroidism	0.00801	0.0265	CbGeAlD
Etoricoxib—Muscular weakness—Levothyroxine—hypothyroidism	0.00785	0.0125	CcSEcCtD
Etoricoxib—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00785	0.0125	CcSEcCtD
Etoricoxib—MAPK14—cerebellum—hypothyroidism	0.00782	0.0259	CbGeAlD
Etoricoxib—Angina pectoris—Levothyroxine—hypothyroidism	0.0075	0.012	CcSEcCtD
Etoricoxib—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0075	0.012	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Liotrix—hypothyroidism	0.00722	0.0115	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.00708	0.0993	CbGpPWpGaD
Etoricoxib—Renal impairment—Liotrix—hypothyroidism	0.00688	0.011	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00676	0.0108	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00676	0.0108	CcSEcCtD
Etoricoxib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00673	0.0107	CcSEcCtD
Etoricoxib—Myocardial infarction—Levothyroxine—hypothyroidism	0.00673	0.0107	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Liotrix—hypothyroidism	0.00668	0.0107	CcSEcCtD
Etoricoxib—Cardiac arrest—Liotrix—hypothyroidism	0.00623	0.00994	CcSEcCtD
Etoricoxib—Blood creatinine increased—Liotrix—hypothyroidism	0.00614	0.00979	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.00594	0.0833	CbGpPWpGaD
Etoricoxib—Muscular weakness—Liotrix—hypothyroidism	0.00578	0.00922	CcSEcCtD
Etoricoxib—Flushing—Dextrothyroxine—hypothyroidism	0.00572	0.00912	CcSEcCtD
Etoricoxib—Flushing—Levothyroxine—hypothyroidism	0.00572	0.00912	CcSEcCtD
Etoricoxib—Abdominal distension—Liotrix—hypothyroidism	0.0057	0.00909	CcSEcCtD
Etoricoxib—Bronchospasm—Liotrix—hypothyroidism	0.00557	0.00888	CcSEcCtD
Etoricoxib—Angina pectoris—Liotrix—hypothyroidism	0.00551	0.0088	CcSEcCtD
Etoricoxib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0055	0.00878	CcSEcCtD
Etoricoxib—Arrhythmia—Levothyroxine—hypothyroidism	0.0055	0.00878	CcSEcCtD
Etoricoxib—Bronchitis—Liotrix—hypothyroidism	0.00544	0.00869	CcSEcCtD
Etoricoxib—Alopecia—Dextrothyroxine—hypothyroidism	0.00544	0.00868	CcSEcCtD
Etoricoxib—Alopecia—Levothyroxine—hypothyroidism	0.00544	0.00868	CcSEcCtD
Etoricoxib—Tremor—Levothyroxine—hypothyroidism	0.00502	0.00802	CcSEcCtD
Etoricoxib—Tremor—Dextrothyroxine—hypothyroidism	0.00502	0.00802	CcSEcCtD
Etoricoxib—MAPK14—Monoamine Transport—SLC5A7—hypothyroidism	0.00502	0.0704	CbGpPWpGaD
Etoricoxib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00498	0.00794	CcSEcCtD
Etoricoxib—Renal failure—Liotrix—hypothyroidism	0.00496	0.00792	CcSEcCtD
Etoricoxib—Myocardial infarction—Liotrix—hypothyroidism	0.00495	0.00789	CcSEcCtD
Etoricoxib—Agitation—Dextrothyroxine—hypothyroidism	0.00493	0.00786	CcSEcCtD
Etoricoxib—Agitation—Levothyroxine—hypothyroidism	0.00493	0.00786	CcSEcCtD
Etoricoxib—Angioedema—Dextrothyroxine—hypothyroidism	0.0049	0.00782	CcSEcCtD
Etoricoxib—Angioedema—Levothyroxine—hypothyroidism	0.0049	0.00782	CcSEcCtD
Etoricoxib—Palpitations—Levothyroxine—hypothyroidism	0.00474	0.00756	CcSEcCtD
Etoricoxib—Palpitations—Dextrothyroxine—hypothyroidism	0.00474	0.00756	CcSEcCtD
Etoricoxib—Arthralgia—Levothyroxine—hypothyroidism	0.00457	0.00728	CcSEcCtD
Etoricoxib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00457	0.00728	CcSEcCtD
Etoricoxib—Anxiety—Levothyroxine—hypothyroidism	0.00455	0.00726	CcSEcCtD
Etoricoxib—Anxiety—Dextrothyroxine—hypothyroidism	0.00455	0.00726	CcSEcCtD
Etoricoxib—CYP2C9—heart—hypothyroidism	0.00452	0.015	CbGeAlD
Etoricoxib—Hypoaesthesia—Liotrix—hypothyroidism	0.00451	0.00719	CcSEcCtD
Etoricoxib—Confusional state—Levothyroxine—hypothyroidism	0.00441	0.00704	CcSEcCtD
Etoricoxib—Confusional state—Dextrothyroxine—hypothyroidism	0.00441	0.00704	CcSEcCtD
Etoricoxib—CYP2C19—blood—hypothyroidism	0.00435	0.0144	CbGeAlD
Etoricoxib—Shock—Levothyroxine—hypothyroidism	0.00431	0.00687	CcSEcCtD
Etoricoxib—Shock—Dextrothyroxine—hypothyroidism	0.00431	0.00687	CcSEcCtD
Etoricoxib—CYP2C9—cardiovascular system—hypothyroidism	0.00427	0.0141	CbGeAlD
Etoricoxib—Flushing—Liotrix—hypothyroidism	0.00421	0.00671	CcSEcCtD
Etoricoxib—PTGS2—adrenal cortex—hypothyroidism	0.00408	0.0135	CbGeAlD
Etoricoxib—Arrhythmia—Liotrix—hypothyroidism	0.00405	0.00646	CcSEcCtD
Etoricoxib—CYP2E1—cardiovascular system—hypothyroidism	0.00404	0.0134	CbGeAlD
Etoricoxib—Alopecia—Liotrix—hypothyroidism	0.004	0.00639	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00399	0.00636	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00399	0.00636	CcSEcCtD
Etoricoxib—Insomnia—Levothyroxine—hypothyroidism	0.00396	0.00632	CcSEcCtD
Etoricoxib—Insomnia—Dextrothyroxine—hypothyroidism	0.00396	0.00632	CcSEcCtD
Etoricoxib—PTGS2—heart—hypothyroidism	0.00395	0.0131	CbGeAlD
Etoricoxib—Dyspnoea—Levothyroxine—hypothyroidism	0.0039	0.00622	CcSEcCtD
Etoricoxib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0039	0.00622	CcSEcCtD
Etoricoxib—Flatulence—Liotrix—hypothyroidism	0.00389	0.0062	CcSEcCtD
Etoricoxib—Dysgeusia—Liotrix—hypothyroidism	0.00386	0.00616	CcSEcCtD
Etoricoxib—Fatigue—Dextrothyroxine—hypothyroidism	0.00377	0.00602	CcSEcCtD
Etoricoxib—Fatigue—Levothyroxine—hypothyroidism	0.00377	0.00602	CcSEcCtD
Etoricoxib—PTGS2—cardiovascular system—hypothyroidism	0.00372	0.0123	CbGeAlD
Etoricoxib—Vision blurred—Liotrix—hypothyroidism	0.00372	0.00593	CcSEcCtD
Etoricoxib—Tremor—Liotrix—hypothyroidism	0.0037	0.0059	CcSEcCtD
Etoricoxib—Agitation—Liotrix—hypothyroidism	0.00362	0.00578	CcSEcCtD
Etoricoxib—Feeling abnormal—Levothyroxine—hypothyroidism	0.00361	0.00575	CcSEcCtD
Etoricoxib—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00361	0.00575	CcSEcCtD
Etoricoxib—Angioedema—Liotrix—hypothyroidism	0.0036	0.00575	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00358	0.00571	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00358	0.00571	CcSEcCtD
Etoricoxib—CYP1A2—blood—hypothyroidism	0.00355	0.0118	CbGeAlD
Etoricoxib—Palpitations—Liotrix—hypothyroidism	0.00349	0.00556	CcSEcCtD
Etoricoxib—Urticaria—Levothyroxine—hypothyroidism	0.00348	0.00555	CcSEcCtD
Etoricoxib—Urticaria—Dextrothyroxine—hypothyroidism	0.00348	0.00555	CcSEcCtD
Etoricoxib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00346	0.00552	CcSEcCtD
Etoricoxib—Abdominal pain—Levothyroxine—hypothyroidism	0.00346	0.00552	CcSEcCtD
Etoricoxib—MAPK14—TSH signaling pathway—PAX8—hypothyroidism	0.00345	0.0484	CbGpPWpGaD
Etoricoxib—CYP1A2—thyroid gland—hypothyroidism	0.00343	0.0114	CbGeAlD
Etoricoxib—Hypertension—Liotrix—hypothyroidism	0.00341	0.00543	CcSEcCtD
Etoricoxib—CYP2C19—liver—hypothyroidism	0.0034	0.0113	CbGeAlD
Etoricoxib—CYP2C9—blood—hypothyroidism	0.00337	0.0112	CbGeAlD
Etoricoxib—Arthralgia—Liotrix—hypothyroidism	0.00336	0.00536	CcSEcCtD
Etoricoxib—Chest pain—Liotrix—hypothyroidism	0.00336	0.00536	CcSEcCtD
Etoricoxib—Anxiety—Liotrix—hypothyroidism	0.00335	0.00534	CcSEcCtD
Etoricoxib—PTGS2—pituitary gland—hypothyroidism	0.0033	0.0109	CbGeAlD
Etoricoxib—Confusional state—Liotrix—hypothyroidism	0.00325	0.00518	CcSEcCtD
Etoricoxib—MAPK14—FAS (CD95) signaling pathway—CLTC—hypothyroidism	0.00324	0.0454	CbGpPWpGaD
Etoricoxib—Anaphylactic shock—Liotrix—hypothyroidism	0.00322	0.00514	CcSEcCtD
Etoricoxib—Oedema—Liotrix—hypothyroidism	0.00322	0.00514	CcSEcCtD
Etoricoxib—CYP2E1—adrenal gland—hypothyroidism	0.0032	0.0106	CbGeAlD
Etoricoxib—Infection—Liotrix—hypothyroidism	0.0032	0.0051	CcSEcCtD
Etoricoxib—CYP2E1—blood—hypothyroidism	0.0032	0.0106	CbGeAlD
Etoricoxib—Shock—Liotrix—hypothyroidism	0.00317	0.00505	CcSEcCtD
Etoricoxib—Asthenia—Dextrothyroxine—hypothyroidism	0.00314	0.00501	CcSEcCtD
Etoricoxib—Asthenia—Levothyroxine—hypothyroidism	0.00314	0.00501	CcSEcCtD
Etoricoxib—Pruritus—Dextrothyroxine—hypothyroidism	0.0031	0.00494	CcSEcCtD
Etoricoxib—Pruritus—Levothyroxine—hypothyroidism	0.0031	0.00494	CcSEcCtD
Etoricoxib—CYP2E1—thyroid gland—hypothyroidism	0.00309	0.0102	CbGeAlD
Etoricoxib—Anorexia—Liotrix—hypothyroidism	0.00307	0.0049	CcSEcCtD
Etoricoxib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00299	0.00478	CcSEcCtD
Etoricoxib—Diarrhoea—Levothyroxine—hypothyroidism	0.00299	0.00478	CcSEcCtD
Etoricoxib—PTGS2—adrenal gland—hypothyroidism	0.00295	0.00975	CbGeAlD
Etoricoxib—PTGS2—blood—hypothyroidism	0.00294	0.00975	CbGeAlD
Etoricoxib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00293	0.00468	CcSEcCtD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00293	0.0411	CbGpPWpGaD
Etoricoxib—Insomnia—Liotrix—hypothyroidism	0.00291	0.00465	CcSEcCtD
Etoricoxib—Dyspnoea—Liotrix—hypothyroidism	0.00287	0.00458	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.00282	0.0395	CbGpPWpGaD
Etoricoxib—Decreased appetite—Liotrix—hypothyroidism	0.0028	0.00446	CcSEcCtD
Etoricoxib—Vomiting—Dextrothyroxine—hypothyroidism	0.00278	0.00444	CcSEcCtD
Etoricoxib—Vomiting—Levothyroxine—hypothyroidism	0.00278	0.00444	CcSEcCtD
Etoricoxib—CYP1A2—liver—hypothyroidism	0.00278	0.00921	CbGeAlD
Etoricoxib—Fatigue—Liotrix—hypothyroidism	0.00278	0.00443	CcSEcCtD
Etoricoxib—Rash—Levothyroxine—hypothyroidism	0.00276	0.0044	CcSEcCtD
Etoricoxib—Rash—Dextrothyroxine—hypothyroidism	0.00276	0.0044	CcSEcCtD
Etoricoxib—Dermatitis—Dextrothyroxine—hypothyroidism	0.00276	0.0044	CcSEcCtD
Etoricoxib—Dermatitis—Levothyroxine—hypothyroidism	0.00276	0.0044	CcSEcCtD
Etoricoxib—Constipation—Liotrix—hypothyroidism	0.00275	0.00439	CcSEcCtD
Etoricoxib—PTGS2—female gonad—hypothyroidism	0.00275	0.00909	CbGeAlD
Etoricoxib—Headache—Levothyroxine—hypothyroidism	0.00274	0.00437	CcSEcCtD
Etoricoxib—Headache—Dextrothyroxine—hypothyroidism	0.00274	0.00437	CcSEcCtD
Etoricoxib—Feeling abnormal—Liotrix—hypothyroidism	0.00265	0.00423	CcSEcCtD
Etoricoxib—CYP2E1—testis—hypothyroidism	0.00265	0.00876	CbGeAlD
Etoricoxib—CYP2C9—liver—hypothyroidism	0.00264	0.00874	CbGeAlD
Etoricoxib—Gastrointestinal pain—Liotrix—hypothyroidism	0.00263	0.0042	CcSEcCtD
Etoricoxib—Nausea—Dextrothyroxine—hypothyroidism	0.0026	0.00415	CcSEcCtD
Etoricoxib—Nausea—Levothyroxine—hypothyroidism	0.0026	0.00415	CcSEcCtD
Etoricoxib—CYP3A4—blood—hypothyroidism	0.00257	0.00852	CbGeAlD
Etoricoxib—Urticaria—Liotrix—hypothyroidism	0.00256	0.00408	CcSEcCtD
Etoricoxib—Abdominal pain—Liotrix—hypothyroidism	0.00254	0.00406	CcSEcCtD
Etoricoxib—CYP2D6—blood—hypothyroidism	0.00253	0.00839	CbGeAlD
Etoricoxib—CYP2E1—liver—hypothyroidism	0.0025	0.00828	CbGeAlD
Etoricoxib—CYP2E1—cerebellum—hypothyroidism	0.00244	0.00809	CbGeAlD
Etoricoxib—MAPK14—EPO signaling pathway—SH2B3—hypothyroidism	0.00239	0.0335	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Liotrix—hypothyroidism	0.00237	0.00378	CcSEcCtD
Etoricoxib—CYP2D6—female gonad—hypothyroidism	0.00236	0.00782	CbGeAlD
Etoricoxib—Asthenia—Liotrix—hypothyroidism	0.00231	0.00368	CcSEcCtD
Etoricoxib—PTGS2—liver—hypothyroidism	0.0023	0.00763	CbGeAlD
Etoricoxib—Pruritus—Liotrix—hypothyroidism	0.00228	0.00363	CcSEcCtD
Etoricoxib—PTGS2—cerebellum—hypothyroidism	0.00225	0.00745	CbGeAlD
Etoricoxib—Diarrhoea—Liotrix—hypothyroidism	0.0022	0.00351	CcSEcCtD
Etoricoxib—Dizziness—Liotrix—hypothyroidism	0.00213	0.0034	CcSEcCtD
Etoricoxib—CYP2D6—testis—hypothyroidism	0.00209	0.00694	CbGeAlD
Etoricoxib—Vomiting—Liotrix—hypothyroidism	0.00205	0.00327	CcSEcCtD
Etoricoxib—Rash—Liotrix—hypothyroidism	0.00203	0.00324	CcSEcCtD
Etoricoxib—Dermatitis—Liotrix—hypothyroidism	0.00203	0.00324	CcSEcCtD
Etoricoxib—Headache—Liotrix—hypothyroidism	0.00202	0.00322	CcSEcCtD
Etoricoxib—CYP3A4—liver—hypothyroidism	0.00201	0.00666	CbGeAlD
Etoricoxib—CYP2D6—liver—hypothyroidism	0.00198	0.00656	CbGeAlD
Etoricoxib—CYP2D6—cerebellum—hypothyroidism	0.00193	0.00641	CbGeAlD
Etoricoxib—Nausea—Liotrix—hypothyroidism	0.00191	0.00305	CcSEcCtD
Etoricoxib—MAPK14—FGF signaling pathway—BGLAP—hypothyroidism	0.00158	0.0222	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—TSHB—hypothyroidism	0.0015	0.0211	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—TSHR—hypothyroidism	0.0015	0.0211	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.00135	0.0189	CbGpPWpGaD
Etoricoxib—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00119	0.0167	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00113	0.0159	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00104	0.0146	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.000834	0.0117	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—VAV3—hypothyroidism	0.000717	0.01	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000674	0.00945	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—PIK3C2A—hypothyroidism	0.000659	0.00924	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000654	0.00918	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.000624	0.00875	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—VAV3—hypothyroidism	0.000589	0.00826	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ZNF764—hypothyroidism	0.000547	0.00767	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.000494	0.00693	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—VAV3—hypothyroidism	0.000492	0.0069	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000466	0.00654	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000451	0.00632	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000448	0.00628	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.00039	0.00547	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CLTC—hypothyroidism	0.000389	0.00546	CbGpPWpGaD
Etoricoxib—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000382	0.00535	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—THRA—hypothyroidism	0.000353	0.00494	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000349	0.0049	CbGpPWpGaD
Etoricoxib—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000309	0.00434	CbGpPWpGaD
Etoricoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000294	0.00413	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—VAV3—hypothyroidism	0.000284	0.00399	CbGpPWpGaD
Etoricoxib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000271	0.0038	CbGpPWpGaD
Etoricoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000268	0.00377	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—SH2B3—hypothyroidism	0.000262	0.00368	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NKX2-5—hypothyroidism	0.000251	0.00352	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000242	0.00339	CbGpPWpGaD
Etoricoxib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000239	0.00335	CbGpPWpGaD
Etoricoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000229	0.00322	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—THRB—hypothyroidism	0.000227	0.00319	CbGpPWpGaD
Etoricoxib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00022	0.00308	CbGpPWpGaD
Etoricoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000218	0.00305	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000215	0.00302	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—IYD—hypothyroidism	0.000206	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CLTC—hypothyroidism	0.0002	0.00281	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—IYD—hypothyroidism	0.000194	0.00272	CbGpPWpGaD
Etoricoxib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000186	0.00261	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VAV3—hypothyroidism	0.000184	0.00257	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VAV3—hypothyroidism	0.00018	0.00252	CbGpPWpGaD
Etoricoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000177	0.00248	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ATP5O—hypothyroidism	0.000175	0.00246	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000165	0.00231	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TPO—hypothyroidism	0.000165	0.00231	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.000164	0.0023	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—VAV3—hypothyroidism	0.000162	0.00227	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TPO—hypothyroidism	0.000155	0.00217	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000154	0.00217	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000153	0.00214	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—IYD—hypothyroidism	0.00015	0.0021	CbGpPWpGaD
Etoricoxib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000144	0.00201	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—IYD—hypothyroidism	0.000138	0.00193	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—IYD—hypothyroidism	0.000136	0.00191	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CLTC—hypothyroidism	0.00013	0.00182	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000127	0.00178	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000127	0.00178	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TPO—hypothyroidism	0.00012	0.00168	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000117	0.00164	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000117	0.00164	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—IYD—hypothyroidism	0.000117	0.00163	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000116	0.00163	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000116	0.00162	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TRH—hypothyroidism	0.000112	0.00157	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF1—hypothyroidism	0.000111	0.00155	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000111	0.00155	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TPO—hypothyroidism	0.00011	0.00154	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TPO—hypothyroidism	0.000109	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PRL—hypothyroidism	0.000102	0.00143	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000101	0.00142	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSHB—hypothyroidism	9.98e-05	0.0014	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSHR—hypothyroidism	9.98e-05	0.0014	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ATP5O—hypothyroidism	9.91e-05	0.00139	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—POMC—hypothyroidism	9.88e-05	0.00139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VAV3—hypothyroidism	9.44e-05	0.00132	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TPO—hypothyroidism	9.32e-05	0.00131	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—IYD—hypothyroidism	9e-05	0.00126	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SH2B3—hypothyroidism	8.89e-05	0.00125	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.63e-05	0.00121	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.65e-05	0.00107	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.62e-05	0.00107	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TSHB—hypothyroidism	7.62e-05	0.00107	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TPO—hypothyroidism	7.19e-05	0.00101	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TSHB—hypothyroidism	7.18e-05	0.00101	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3C2A—hypothyroidism	6.79e-05	0.000953	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.7e-05	0.00094	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRL—hypothyroidism	6.6e-05	0.000925	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	6.4e-05	0.000897	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VAV3—hypothyroidism	6.1e-05	0.000856	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRL—hypothyroidism	6.02e-05	0.000844	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AVP—hypothyroidism	5.88e-05	0.000825	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC5A5—hypothyroidism	5.71e-05	0.0008	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TSHB—hypothyroidism	5.54e-05	0.000776	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC5A5—hypothyroidism	5.37e-05	0.000753	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TSHB—hypothyroidism	5.09e-05	0.000714	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TSHB—hypothyroidism	5.05e-05	0.000708	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	4.93e-05	0.000692	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.87e-05	0.000683	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.54e-05	0.000636	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	4.5e-05	0.000631	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.44e-05	0.000623	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TSHB—hypothyroidism	4.31e-05	0.000605	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	4.14e-05	0.000581	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—hypothyroidism	3.91e-05	0.000548	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.84e-05	0.000539	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.81e-05	0.000535	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.79e-05	0.000532	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	3.78e-05	0.00053	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—hypothyroidism	3.76e-05	0.000527	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TSHB—hypothyroidism	3.33e-05	0.000467	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC5A5—hypothyroidism	3.23e-05	0.000453	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—hypothyroidism	2.99e-05	0.000419	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.97e-05	0.000416	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—hypothyroidism	2.81e-05	0.000394	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.49e-05	0.00035	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—hypothyroidism	2.17e-05	0.000304	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—hypothyroidism	1.99e-05	0.00028	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—hypothyroidism	1.98e-05	0.000277	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—hypothyroidism	1.69e-05	0.000237	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—hypothyroidism	1.3e-05	0.000183	CbGpPWpGaD
